Mike P. Spence

Statistics

Publications

Citations

150

H-Index

Active since

2005

Affiliations

AstraZeneca (United Kingdom)(Current)

Mike P. Spence is an author at AstraZeneca (United Kingdom) specializing in oncology, pharmacokinetics of anticancer drugs, and tyrosine kinase inhibitors.

Publications per year

2005–2006

Publications

Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor

David McKillop, E. A. Partridge, John Kemp et al. · Molecular Cancer Therapeutics · 2005 · 125 citations

Medicine, Oncology, Pharmacology +16

Minimal contribution of desmethyl-gefitinib, the major human plasma metabolite of gefitinib, to epidermal growth factor receptor (EGFR)-mediated tumour growth inhibition

D. McKillop, Simon P. Guy, Mike P. Spence et al. · Xenobiotica · 2006 · 25 citations

Medicine, Oncology, Pharmacology +13

1–2 of 2